THRUST EN Stock OTC Bulletin Board
Equities
TEGC
US88602Q1094
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2022 | - | Sales 2023 | 410K | Capitalization | 353K |
---|---|---|---|---|---|
Net income 2022 | -3M | Net income 2023 | -3M | EV / Sales 2022 | - |
Net Debt 2022 | 1.64M | Net Debt 2023 | 1.21M | EV / Sales 2023 | 3.82 x |
P/E ratio 2022 |
-1.12
x | P/E ratio 2023 |
-0.04
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Eyal Barad
FOU | Founder | 58 | 04-09-14 |
Gabriel Yariv
CHM | Chairman | 47 | 19-10-06 |
Uri Ben-Or
DFI | Director of Finance/CFO | 52 | 16-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eyal Barad
FOU | Founder | 58 | 04-09-14 |
Gabriel Yariv
CHM | Chairman | 47 | 19-10-06 |
1st Jan change | Capi. | |
---|---|---|
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.47% | 16.37B | |
+2.23% | 13.58B | |
+27.13% | 11.66B |
- Stock Market
- Equities
- CNBX Stock
- TEGC Stock